What diagnostic tests should be ordered for a patient with hematuria who has benign prostatic hyperplasia and is taking aspirin?

Diagnostic Workup for Hematuria in a Patient with BPH on Aspirin

This patient requires a complete urologic evaluation including urinalysis with microscopy, upper tract imaging (preferably CT urography), and cystoscopy—the aspirin therapy should NOT delay or alter this workup. 1

Critical First Principle: Aspirin Does Not Excuse Hematuria

Anticoagulant or antiplatelet therapy (including aspirin) is never an acceptable explanation for hematuria and does not change the evaluation approach. 2, 1 While BPH is a known benign cause of hematuria 2, approximately 25% of patients on aspirin or warfarin with gross hematuria have an underlying malignancy 3, making full evaluation mandatory.

Initial Laboratory Testing

Order immediately:

• Urinalysis with microscopic examination - Confirm true hematuria (≥3 RBCs/HPF), assess for dysmorphic RBCs, red cell casts, proteinuria, and infection 4
• Urine culture - If infection suspected, obtain before antibiotics 2
• Serum creatinine - Assess renal function 4

Do NOT order:

• Urinary cytology or urine-based molecular markers - These are specifically NOT recommended in initial hematuria evaluation 1

Imaging of Upper Urinary Tract

The preferred imaging study is CT urography (multiphase protocol with unenhanced, nephrographic, and excretory phases). 2 This is the ACR Appropriateness Criteria gold standard for hematuria evaluation 2.

Key considerations:

• CT urography has superior sensitivity for detecting urothelial malignancies compared to ultrasound
• If CT contraindicated (renal insufficiency, contrast allergy), consider MR urography 2
• Ultrasound alone is insufficient for complete upper tract evaluation in hematuria workup

Cystoscopy

Cystoscopy is mandatory and should be performed regardless of imaging findings. 4, 5 The sensitivity of white light cystoscopy for bladder cancer ranges from 47-100% with specificity 93-100% 5.

Timing considerations with aspirin:

• Flexible cystoscopy can be safely performed while continuing aspirin 6
• The small increased risk of minor rectal bleeding (self-limited) does not justify stopping aspirin 6
• If therapeutic intervention is needed during cystoscopy, discuss aspirin management with cardiology based on thrombotic risk

Risk Stratification Context

This patient has multiple risk factors warranting aggressive evaluation:

• Male gender - Higher malignancy risk 2
• BPH history - While benign, doesn't exclude concurrent malignancy 2
• Gross vs microscopic hematuria - If gross hematuria, malignancy risk is 30-40%; if microscopic, risk is 2.6-4% 2

Common Pitfalls to Avoid

1. Attributing hematuria solely to BPH or aspirin - Both can coexist with malignancy 2, 3
2. Ordering only ultrasound - Insufficient for complete upper tract evaluation 2
3. Stopping aspirin unnecessarily - Increases thrombotic risk without meaningful reduction in diagnostic complications 1, 6
4. Obtaining urinary cytology - Wastes resources and doesn't change management 1
5. Delaying evaluation - Even self-limited gross hematuria requires full workup 1

If Urinary Tract Infection is Present

Treat infection appropriately and repeat urinalysis 6 weeks after treatment. If hematuria resolves, no further evaluation needed. If persistent, proceed with full urologic workup 4.

Follow-up if Initial Workup is Negative

If complete evaluation is negative, follow semi-annually for 3 years with repeat urinalysis to monitor for delayed presentation of malignancy 7.